{"transactions":[{"id":3299054,"issuer":{"id":12234,"kind":"organization","name":"ACHILLION PHARMACEUTICALS INC","symbol":"ACHN"},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-01-29T16:13:22.000Z","date":"2020-01-28","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Subject to certain conditions, at the effective time, all unexercised options with an exercise price below $6.30 were cancelled and converted into the right to receive (i) a cash payment of (A) $6.30 less the exercise price, multiplied by (B) the number of shares subject thereto and (ii) one CVR per share subject thereto. Options with an exercise price of $6.30 or greater were cancelled and converted into the right to receive a cash payment with respect to each share subject thereto upon each milestone payment date equal to (i) the amount by which, as of the payment date, the sum of (x) $6.30, (y) the amount per share previously paid in respect of any earlier payment date and (z) the amount in cash to be paid at such payment date exceeds the exercise price payable under such option, less (ii) the amount of all payments previously received with respect to such option. Options with an exercise price of $8.30 or greater were cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 28, 2020, Achillion Pharmaceuticals, Inc. (\"Achillion\") consummated a merger pursuant to the merger agreement among Achillion, Alexion Pharmaceuticals, Inc. (\"Alexion\") and Beagle Merger Sub, Inc. Shareholders received (i) cash consideration of $6.30 per share and (ii) one contingent value right (\"CVR\") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471."}],"balance_after":0,"derivative":{"exercise_price":2.18,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-20-000669","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070336/000156218020000669/primarydocument.xml","form_type":"4"}},{"id":3299053,"issuer":{"id":12234,"kind":"organization","name":"ACHILLION PHARMACEUTICALS INC","symbol":"ACHN"},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2020-01-29T16:13:22.000Z","date":"2020-01-28","kind":"disposition_to_issuer","acquired":false,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Subject to certain conditions, at the effective time, all unexercised options with an exercise price below $6.30 were cancelled and converted into the right to receive (i) a cash payment of (A) $6.30 less the exercise price, multiplied by (B) the number of shares subject thereto and (ii) one CVR per share subject thereto. Options with an exercise price of $6.30 or greater were cancelled and converted into the right to receive a cash payment with respect to each share subject thereto upon each milestone payment date equal to (i) the amount by which, as of the payment date, the sum of (x) $6.30, (y) the amount per share previously paid in respect of any earlier payment date and (z) the amount in cash to be paid at such payment date exceeds the exercise price payable under such option, less (ii) the amount of all payments previously received with respect to such option. Options with an exercise price of $8.30 or greater were cancelled without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On January 28, 2020, Achillion Pharmaceuticals, Inc. (\"Achillion\") consummated a merger pursuant to the merger agreement among Achillion, Alexion Pharmaceuticals, Inc. (\"Alexion\") and Beagle Merger Sub, Inc. Shareholders received (i) cash consideration of $6.30 per share and (ii) one contingent value right (\"CVR\") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471."}],"balance_after":0,"derivative":{"exercise_price":3.32,"expiration_date":"2028-09-11","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001562180-20-000669","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070336/000156218020000669/primarydocument.xml","form_type":"4"}},{"id":3686960,"issuer":{"id":12234,"kind":"organization","name":"ACHILLION PHARMACEUTICALS INC","symbol":"ACHN"},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2019-01-25T16:47:29.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter."}],"balance_after":200000,"derivative":{"exercise_price":2.18,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-005365","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070336/000120919119005365/doc4.xml","form_type":"4"}},{"id":3818693,"issuer":{"id":12234,"kind":"organization","name":"ACHILLION PHARMACEUTICALS INC","symbol":"ACHN"},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option","published_at":"2018-09-12T17:57:09.000Z","date":"2018-09-11","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter."}],"balance_after":400000,"derivative":{"exercise_price":3.32,"expiration_date":"2028-09-11","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-18-050688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070336/000120919118050688/doc4.xml","form_type":"4"}},{"id":4084620,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-30T16:31:52.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":22843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":22843,"derivative":{"exercise_price":19.39,"expiration_date":"2028-01-26","underlying":"Ordinary Shares","underlying_shares":22843},"source":{"system":"sec-edgar","filing":"0000904454-18-000070","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445418000070/edgar.xml","form_type":"4"}},{"id":4084619,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-01-30T16:31:52.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":8566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share.  The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":93817,"source":{"system":"sec-edgar","filing":"0000904454-18-000070","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445418000070/edgar.xml","form_type":"4"}},{"id":4110400,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-01-03T22:50:33.000Z","date":"2018-01-03","kind":"sale","acquired":false,"shares":5864,"price":20.1276,"value":118028.2464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As required by the relevant Restricted Share Unit Agreement, the reporting person sold the ordinary shares and remitted the proceeds therefrom to the issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.66 to $20.47, inclusive. The reporting person undertakes to provide uniQure N.V., any security holder of uniQure N.V. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consists of (i) 11,636 ordinary shares, (ii) 56,115 performance share units that vest in full on January 27, 2020 and (iii) 17,500 restricted stock\nunits previously disclosed by the reporting person on Table II, that vest in full on December 31, 2018."}],"balance_after":85251,"source":{"system":"sec-edgar","filing":"0001209191-18-001200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000120919118001200/doc4.xml","form_type":"4"}},{"id":4129907,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2017-12-15T21:34:19.000Z","date":"2017-12-13","kind":"grant","acquired":true,"shares":56115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On January 27, 2017, the uniQure Board of Directors approved a grant to Mr. Firuta of 43,500 performance share units linked to the achievement of specified performance goals in 2017. On December 13, 2017, the Board of Directors determined that certain performance goals were met.  Following the Board's determination, each performance share unit represents the right to receive one ordinary share, and will vest in full on January 27, 2020."}],"balance_after":56115,"source":{"system":"sec-edgar","filing":"0001209191-17-065946","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000120919117065946/doc4.xml","form_type":"4"}},{"id":4435251,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Preformance Share Unit","published_at":"2017-02-21T22:04:35.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":43500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."}],"balance_after":43500,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":43500},"source":{"system":"sec-edgar","filing":"0001140361-17-008376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000114036117008376/doc1.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4435250,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-21T22:04:35.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":43000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Due to clerical error, the Form 4, as originally filed, incorrectly reports the number of options granted as 43,250 and the number of performance share units granted as 43,250. The Form 4, as amended by this Form 4/A, correctly reports such information."}],"balance_after":43000,"derivative":{"exercise_price":5.37,"expiration_date":"2027-01-27","underlying":"Ordinary Shares","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001140361-17-008376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000114036117008376/doc1.xml","form_type":"4/A","original_submission_date":"2017-01-31"}},{"id":4474956,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Preformance Share Unit","published_at":"2017-01-31T20:23:31.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":43250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Performance Shares Units of a maximum of 43,250 shares of the Company's Ordinary Shares were granted on January 27, 2017. The Board of Directors shall determine how many Performance Share Units are to be granted in conjunction with a review of certain performance goals associated with the grant. Any such Performance Share Units granted by the Board of Directors shall vest 100% on January 27, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Expiration date is not applicable."}],"balance_after":43250,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":43250},"source":{"system":"sec-edgar","filing":"0001140361-17-003717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000114036117003717/doc1.xml","form_type":"4"}},{"id":4474955,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":152149,"kind":"person","name":"Firuta Paul E","position":1,"cik":"0001602727","reported_name":"Firuta Paul E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T20:23:31.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":43250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option vests 25% on January 27, 2018 and 6.25% quarterly thereafter until fully vested."}],"balance_after":43250,"derivative":{"exercise_price":5.37,"expiration_date":"2027-01-27","underlying":"Ordinary Shares","underlying_shares":43250},"source":{"system":"sec-edgar","filing":"0001140361-17-003717","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000114036117003717/doc1.xml","form_type":"4"}}]}